Merck KGaA pledges $50M to new biotech with eye to acquisition
Merck KGaA committed $50M to launch a new cardiovascular biotech, with plans to acquire the company once its pipeline matures.
Merck KGaA
Profile of Merck KGaA created from news harvest. To be enriched by user.
Company Info
Sector:Science & Technology / Healthcare (E.Merck)
Headquarters:Darmstadt, Germany
Founded:1668
Website:www.emdgroup.com/en
Clinical Development Pipeline
Undisclosed
Target: TBDRecent News
Leadership Team
Kai Beckmann
Chief Executive Officer (effective May 2026)
Careers & Job Openings